ArcaScience
The company has since developed AI technology that radically improves benefit-risk assessments for pharmaceuticals, giving regulators, clinical teams, and patients tools to make better, safer decisions.
ArcaScience has raised €6.0M across 1 funding round from 5 investors, most recently a Seed round in Sep 2025. Based in Paris, France; active in Software. Data as of 28 Oct 2026.
Paris, Francewww.arcascience.ai ↗
Total raised
€6.0M
€6,010,131
Funding rounds
1
Investors
5
distinct backers
Active since
2025-09
latest 2025-09
Funding by year
EUR raised per yearArcaScience — funding by year — interactive chart.
Data table
| ArcaScience — funding by year | |
|---|---|
| 2025 | €6.0M |
Signals
High confidenceRaise-next likelihood62
base rate 44% for Seed
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-09-04 | Seed | €6.0M | AKKA Technologies,Bpifrance,Pleiade Venture,Plug & Play Ventures,The Moon Venture | View deal → |
Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- DAZN€3.8BUK · Software
- Visma€3.0BNorway · Software
- Verkor€2.4BFrance · Energy
- Celonis€2.2BGermany · Software
Global coverage: FundingData